Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δευτέρα 7 Αυγούστου 2017
Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics
Publication date: Available online 7 August 2017 Source:Journal of Allergy and Clinical Immunology Author(s): Phillip L. Lieberman, Ilisten Jones, Richa Rajwanshi, Karin Rosén, Dale T. Umetsu
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου